"This is the first stem cell trial in the cornea in the U.S., and is paving the way for further treatments of this sort," Jurkunas told ABC News. When the cells are depleted in the cornea ...

In the first clinical study of its kind, researchers at Tokyo's Keio University have developed a stem cell treatment that they say allowed a paralyzed man to stand on his own again following a ...

A stem cell transplant can be a good treatment for multiple myeloma. A successful transplant gives someone with multiple myeloma new, healthy bone marrow. It replaces the bone marrow harmed by myeloma ...

If cells are removed from the embryo they will differentiate into any cell type. These are called embryonic stem cells. Some stem cells remain in the bodies of adults as adult stem cells.

To retrieve the sperm, a sliver of tissue is cut away from the skin—a less invasive procedure than the stem cell transplant, which requires opening up the testis. When Orwig’s team first ...

Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson’s disease. The papers, published in Nature, investigate the use of cells derived from human ...

But in an unexpected twist, the company added the development and manufacturing of stem-cell-therapy products to its portfolio, which gave them the idea of creating original cell-culture media.

Over the next decade, stem cell technology is expected to become even more refined. Treatments are anticipated to become increasingly personalized and tailored to individual needs.

Steroid-refractory acute GvHD is a serious and life-threatening condition that can occur as a complication of donor haematopoietic stem cell transplantation (HSCT), used to treat blood cancers and ...

Bayer subsidiary BlueRock Therapeutics has been granted a fast-track review by the FDA for DA01, its stem cell-based therapy for Parkinson's disease which is currently in early-stage clinical testing.